Contact Information: Contact: Ralph Barry Chief Business Officer Aegis Therapeutics LLC 1-858-618-1400 Ext. 102 Email: Email Contact
Aegis Therapeutics to Present at the "2nd Modern Drug Discovery & Development Summit" in Philadelphia in December 2006
| Source: Aegis Therapeutics
SAN DIEGO, CA -- (MARKET WIRE) -- November 16, 2006 -- Aegis Therapeutics, a leader in intranasal
drug delivery, will present a talk entitled: "High-Efficiency Transmucosal
Delivery of Peptide and Protein Therapeutics" at the "2nd Modern Drug
Discovery & Development Summit" presented by GTCbio. Dr. Edward T. Maggio,
President and CEO of Aegis, will describe the application of Aegis'
Intravail™ non-invasive drug delivery technology, and Aegis' ProTek™
protein stabilization technology to specific peptide and protein
therapeutics. The presentation is scheduled for Tuesday, December 5, 2006
at the Pennsylvania Convention Center, Philadelphia, PA.
Information about the conference may be obtained from the following
website: http://gtcbio.com/confpage.asp?cid=8
About Aegis Therapeutics
Aegis Therapeutics LLC is a drug delivery technology company
commercializing its patented or proprietary drug delivery and drug
formulation technologies through product-specific licenses. Our
Intravail® drug delivery technology enables the non-invasive delivery of
a broad range of protein, peptide and non-peptide macromolecular
therapeutics that can currently only be administered by injection. Aegis'
Intravail® absorption enhancement agents provide exceptionally high and
unmatched bioavailability performance, comparable in efficiency to
subcutaneous injection, via the intranasal and other mucosal membrane
administration routes. Our ProTek™ technology allows creation of
proprietary, easily manufacturable, and stable aqueous or lyophilized
dosage forms that maintain the integrity and physiological activity of many
protein and peptide therapeutics. ProTek™ technology is applicable to
injectable, intranasal, and other dosage forms of peptide or protein
therapeutics.
For more information about Aegis, please visit the Aegis website at:
http://www.aegisthera.com.